Passage Bio financial statements

패시지 바이오NASDAQ:PASG · Nasdaq · Healthcare · sector #16
$4.08-0.24%
2026-10-06 close · prelim

Passage Bio's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$70M.

Reported results

Passage Bio notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q